HOB Biotech Group Corp.,Ltd (SHSE: 688656)
Health Care · Biotechnology · CN
CN¥120.00
-8.90% today · -20.0% 1Y
HOB Biotech Group Corp.,Ltd (SHSE: 688656) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.12B and employs 525 people.
Over the last twelve months the share price has lost 20.0%, trading between 76.62 and 217.00.
Tweenvest scores HOB Biotech Group Corp.,Ltd across four factors: quality 73/100, value 11/100, growth 14/100, dividend 13/100. Its strongest factor is quality.
688656 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.12B
- Revenue (TTM)
- $59.55M
- P/E
- 266.62
- EPS
- 0.45
- Dividend yield
- 0.17%
- Beta (5Y)
- -0.34
- 52-week high
- CN¥217.00
- 52-week low
- CN¥76.62
- Avg volume (3M)
- —
- Shares outstanding
- 62.72M
- Employees
- 525
- Next earnings
- —
About HOB Biotech Group Corp.,Ltd
HOB Biotech Group Corp.,Ltd. is an international in vitro diagnostics firm, active in both China and various global markets. It supplies advanced diagnostic assays, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immunoassays, to laboratories and hospitals. This endeavor aims to improve the treatment and care for patients afflicted with allergies and autoimmune diseases. The company was established in 2009 and is headquartered in Suzhou, China.
- ISIN
- CNE100004C37
- Founded
- 2009
- Listed since
- Jan 13, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Amoy Diagnostics Co., Ltd.SZSE: 300685 | $1.16B | CN¥20.30 | -4.87% |
| Nanjing Leads Biolabs Co., Ltd.SEHK: 9887 | $1.13B | HK$45.56 | -9.69% |
| L&C BIO Co.,LTDKOSDAQ: A290650 | $1.13B | ₩56,400.00 | +5.03% |
| Janux Therapeutics, Inc.NasdaqGM: JANX | $1.12B | $18.39 | +8.62% |
| China Resources Boya Bio-pharmaceutical Group Co.,LtdSZSE: 300294 | $1.12B | CN¥14.88 | -0.40% |
| Oncolys BioPharma Inc.TSE: 4588 | $1.11B | ¥5,970.00 | -0.17% |
| Changchun BCHT Biotechnology Co.SHSE: 688276 | $1.10B | CN¥17.79 | -0.89% |
| GC Biopharma Corp.KOSE: A006280 | $1.10B | ₩129,400.00 | +2.86% |
Figures last refreshed Oct 11, 2026.